Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CHOP Followed by Iodine-131-Labeled Monoclonal Anti-B1 Antibody for Treatment of Newly Diagnosed Follicular Non-Hodgkin's Lymphomas
NCT00003784Phase 2Completed
- Sponsor
- SWOG Cancer Research Network
- Start
- May 1999
- Primary completion
- Jan 2003
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of tositumomab + iodine-131 tositumomab in follicular lymphoma (FL), sponsored by SWOG Cancer Research Network. Started May 1999; status: completed.
02
Drugs
tositumomab + iodine-131 tositumomab
03
Conditions
follicular lymphoma (FL)
Beyond the preview
Go deeper on NCT00003784.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003784.